Snowball logo
logo
6677

Anxo Pharmaceutical Co., Ltd.

6677 TWO
NT$16.50NT$0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025
Revenue
Total revenue
824.1866.3939.9895.3843.3
COGS
492.4534.8543569.8543.1
Gross Profit
331.7331.5396.9325.5300.2
Operating Expenses & Income
Operating Income
40.15.94553.15(56.42)(42.91)
Total Operating Expenses
291.8325.2343.6381.9886.2
R&D Expenses
111.4139.6139.2148.4131.1
Selling General & Admin Expenses
83.5793.56104114.6212
Earnings from Continuing Operations
Interest Expense
(12.76)(15.19)(18.07)(16.68)(16.64)
Interest Income
1.121.6513.8875.5694.37
Income Tax Expense
4.5862.3277.882(5.919)-
Net Income
Net Income
19.23(12.56)21.86(57.21)(34.13)
Supplemental
EBIT
36.8410.7456.76(43.34)-
EBITDA
111.284.96131.333.37-
In millions of TWD, except % and values per 1 share